Brucellosis Vaccine Challegne Project: 2019 Interim Assessment

Abstract

This assessment by External Evaluator Abt Associates reflects the experience of competitors in the Brucellosis Vaccine Challenge Project from mid-2018 to mid-2019. Most competitors reported that the competition had helped advance their B. melitensis vaccine R&D. However, many of them anticipated challenges completing the safety and efficacy trials due to resource constraints. This work is part of the AgResults programme